Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$468M |
| 2 |
Johnson & Johnson
JNJ
|
+$440M |
| 3 |
IBM
IBM
|
+$355M |
| 4 |
Booking.com
BKNG
|
+$332M |
| 5 |
RAI
Reynolds American Inc
RAI
|
+$331M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LLTC
Linear Technology Corp
LLTC
|
+$482M |
| 2 |
Walt Disney
DIS
|
+$247M |
| 3 |
Visa
V
|
+$219M |
| 4 |
Deere & Co
DE
|
+$200M |
| 5 |
Johnson Controls International
JCI
|
+$179M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.02% |
| 2 | Technology | 13.31% |
| 3 | Financials | 12.25% |
| 4 | Industrials | 9.65% |
| 5 | Consumer Staples | 9.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3001
Solitario Resources
XPL
$73.6M
| $194K | ﹤0.01% |
236,800
+41,500
| +21% | +$31.6K |
|
|
XPLR
3002
DELISTED
Xplore Technologies Corp.
XPLR
| $194K | ﹤0.01% |
94,700
-8,300
| -8% | -$18.1K |
|
|
JONE
3003
DELISTED
Jones Energy, Inc.
JONE
| $193K | ﹤0.01% |
3,779
-14,446
| -79% | -$1.03M |
|
|
GLOG
3004
DELISTED
GASLOG LTD
GLOG
| $192K | ﹤0.01% |
12,500
-12,600
| -50% | -$202K |
|
|
ENTL
3005
DELISTED
Entellus Medical, Inc. Common Stock
ENTL
| $192K | ﹤0.01% |
13,900
-64,900
| -82% | -$1.04M |
|
3006
Atlantic American Corp
AAME
$30.2M
| $191K | ﹤0.01% |
47,700
+600
| +1% | +$2.3K |
|
|
NBSE
3007
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
| $191K | ﹤0.01% |
574
+406
| +242% | +$188K |
|
3008
eGain
EGAN
$200M
| $187K | ﹤0.01% |
129,100
+31,700
| +33% | +$62.4K |
|
3009
CPI Aerostructures
CVU
$72.6M
| $185K | ﹤0.01% |
27,394
-10,406
| -28% | -$82.3K |
|
|
KZIA
3010
Kazia Therapeutics
KZIA
$146M
| $185K | ﹤0.01% |
687
| – | – |
|
|
MTR
3011
Mesa Royalty Trust
MTR
$5.31M
| $184K | ﹤0.01% |
+13,910
| New | +$167K |
|
|
MTVA
3012
MetaVia Inc
MTVA
$7.59M
| – | – |
0
| – | – |
|
|
EMITF
3013
DELISTED
Elbit Imaging Ltd
EMITF
| $183K | ﹤0.01% |
53,713
+1,600
| +3% | +$5.47K |
|
|
GFN
3014
DELISTED
General Finance Corporation
GFN
| $183K | ﹤0.01% |
35,972
+7,276
| +25% | +$37.6K |
|
|
NRT
3015
North European Oil Royalty Trust
NRT
$83.5M
| $181K | ﹤0.01% |
25,052
-25,700
| -51% | -$187K |
|
3016
Costamare
CMRE
$1.71B
| $179K | ﹤0.01% |
26,871
-119,829
| -82% | -$728K |
|
3017
Mega Matrix
MPU
$14.4M
| $176K | ﹤0.01% |
90,000
+6,500
| +8% | +$13.2K |
|
3018
Stabilis Solutions
SLNG
$102M
| $174K | ﹤0.01% |
10,125
+37
| +0.4% | +$558 |
|
|
FCSC
3019
DELISTED
Fibrocell Science Inc.
FCSC
| $174K | ﹤0.01% |
17,373
+4,440
| +34% | +$49.3K |
|
3020
Mastech Digital
MHH
$92.7M
| $170K | ﹤0.01% |
46,200
-4,000
| -8% | -$13.3K |
|
|
SORL
3021
DELISTED
SORL Auto Parts, Inc.
SORL
| $169K | ﹤0.01% |
43,700
-112,300
| -72% | -$342K |
|
3022
Peraso
PRSO
$10.4M
| $167K | ﹤0.01% |
100
+66
| +194% | +$132K |
|
3023
iRadimed
IRMD
$1.12B
| $166K | ﹤0.01% |
18,618
-7,682
| -29% | -$71.2K |
|
|
ZX
3024
DELISTED
China Zenix Auto Internatl Ltd
ZX
| $166K | ﹤0.01% |
109,000
+9,400
| +9% | +$13.6K |
|
3025
ReWalk Robotics
LFWD
$21.8M
| $165K | ﹤0.01% |
37
+14
| +61% | +$66.4K |
|
Similar funds
Jim Simons's Q1 2017 Portfolio in Review
As of Q1 2017, Jim Simons held 3,652 positions worth $71.6B, up 13% from $63.2B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Jim Simons deployed $5.19B of net new capital in Q1 2017, opening 433 new positions and adding to 1,585 existing holdings. Its largest new stake was Merck: 7,716,460 shares worth $468M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Walt Disney, an estimated $247M trimmed.
- Jim Simons's largest Q1 2017 buy was Merck: 7,716,460 shares worth $468M.
- Jim Simons added most to Johnson & Johnson in Q1 2017, an estimated $440M increase.
- Jim Simons's biggest Q1 2017 reduction was Walt Disney, cutting an estimated $247M.
- Jim Simons fully exited Linear Technology Corp in Q1 2017, selling an estimated $482M.
- Jim Simons's ten largest holdings make up 7.9% of its $71.6B portfolio in Q1 2017.
- Jim Simons opened 433 new positions and closed 462 in Q1 2017.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $71.6B.
Based on Renaissance Technologies's 13F filing for Q1 2017, filed 12 May 2017.